MARC보기
LDR02220nmm uu200457 4500
001000000332489
00520240805170902
008181129s2018 |||||||||||||||||c||eng d
020 ▼a 9780438031364
035 ▼a (MiAaPQ)AAI10787455
035 ▼a (MiAaPQ)umn:19075
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 248032
0820 ▼a 575
1001 ▼a Harding, Taylor Stiver.
24510 ▼a Pre-Clinical Strategies to Overcome Drug-Resistant Multiple Myeloma: Predictive Transcriptomics and Targeting the Myeloma Epigenome.
260 ▼a [S.l.] : ▼b University of Minnesota., ▼c 2018
260 1 ▼a Ann Arbor : ▼b ProQuest Dissertations & Theses, ▼c 2018
300 ▼a 179 p.
500 ▼a Source: Dissertation Abstracts International, Volume: 79-10(E), Section: B.
500 ▼a Includes supplementary digital materials.
500 ▼a Adviser: Brian Van Ness.
5021 ▼a Thesis (Ph.D.)--University of Minnesota, 2018.
520 ▼a Multiple myeloma remains an incurable hematological malignancy due to the failure of standard-of-care therapies to broadly target a genetically heterogeneous disease and an inability overcome inevitable drug-resistant relapse. This dissertation
520 ▼a First, our goal was to develop a gene expression signature that predicts response specific to proteasome inhibitor (PI) treatment in MM. Using a well-characterized panel of human myeloma cell lines (HMCLs) representing the biological and genetic
520 ▼a Epigenetic abnormalities are abundantly present in multiple myeloma and accumulating evidence suggests that the histone methyltransferase EZH2 is aberrantly active in MM. We tested the efficacy of EZH2 specific inhibitors in a large panel of hum
590 ▼a School code: 0130.
650 4 ▼a Genetics.
650 4 ▼a Molecular biology.
650 4 ▼a Bioinformatics.
690 ▼a 0369
690 ▼a 0307
690 ▼a 0715
71020 ▼a University of Minnesota. ▼b Biological Science.
7730 ▼t Dissertation Abstracts International ▼g 79-10B(E).
773 ▼t Dissertation Abstract International
790 ▼a 0130
791 ▼a Ph.D.
792 ▼a 2018
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T14997397 ▼n KERIS
980 ▼a 201812 ▼f 2019
990 ▼a 관리자